LNK augmented the p-AKT, p-MAPK and ERK1/2 pathways, promoted cell migration, enhanced cell adhesion, and promoted the in vivo tumor growth and migration in vivo xenograft tumor model. The gene discussed is AKT1; the disease is neoplasm.